774914

Cumberland Pharmaceuticals, Inc. — FEI 3003258245

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 4, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Nashville, TN (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)